棕酸化增强了甲酸在肠道炎症中的免疫调节作用
Raúl Domínguez-Perles1, Concepción Medrano-Padial1, Cristina García-Viguera1
1Laboratorio de Fitoquímica y Alimentos Saludables (LabFAS), CSIC, CEBAS, Campus Universitario de Espinardo, Edificio 25, 30100 Murcia, Spain.
Biomolecules
|August 28, 2025
概括
棕甲基甲酸盐 (PEGCG) 通过更有效地减少特定的炎症性白内素,显示出较强的抗炎作用. 这种脂性修饰具有治疗IBD等免疫媒介疾病的潜力.
科学领域:
- 免疫学
- 药理学
- 胃肠病学
背景情况:
- 脂和棕甲基酸盐 (PEGCG) 一样结合了和脂质部分,提高了生物活性和治疗潜力.
- PEGCG是甲基甲酸 (EGCG) 的脂性衍生物,其稳定性和生物可用性得到改善,使其成为治疗炎症性肠病 (IBD) 等免疫媒介疾病的候选药物.
- 脂性化对PEGCG抗炎和自身免疫反应抑制的具体作用仍未得到充分研究.
研究的目的:
- 调查EGCG和PEGCG在炎症条件下调节肠上皮的互白素特征的差异有效性.
- 评估PEGCG的脂质性对其抑制炎症和自身免疫反应的能力.
- 为了比较EGCG和PEGCG对巨细胞迁移,极化和细胞因子分泌的影响.
主要方法:
- 在暴露于炎症刺激的肠上皮质中检测互白素的体外分析.
- 使用THP-1衍生的巨细胞评估巨细胞迁移和偏离 (M1/M2表型).
- 通过巨细胞分泌的亲和抗炎细胞因子的量化.
主要成果:
- 通过减少巨细胞迁移和偏离,EGCG和PEGCG都减弱了免疫反应.
- 与EGCG相比,PEGCG在调节白蛋白反应方面具有功能优势,更有效地降低IL- 1β和IL- 12p70的表达.
- 虽然这两种化合物同样降低了关键的促炎性白内素 (IL-6,IL-17,IL-18,IL-23,TNF-α),但PEGCG显示出对IL-1β和IL-12p70的优异抑制.
结论:
- 像EGCG这样的化合物的脂化通过改善膜相互作用和细胞信号干扰来增强它们作为功能分子的潜力.
- 与EGCG相比,PEGCG在调节特定的炎症媒介方面表现出更高的有效性,这表明它在治疗免疫媒介病理方面具有更大的潜力.
- 这些发现支持治疗性应用的脂的开发,特别是在治疗IBD等炎症和自身免疫性疾病时.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.7K
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
1.9K
相关概念视频
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...